Datapoint: Centene to Sell Apixio

Centene Corp. last week said it will sell Apixio, its value-based care and artificial intelligence (AI) platform, to private equity firm New Mountain Capital for an undisclosed sum. The company, which originally acquired Apixio in 2015, said that the transaction will be neutral for 2023 earnings. This is the latest in a series of divestments and spinoffs orchestrated by Centene’s senior leadership, who are in the process of refocusing on Centene’s core health benefits businesses. The insurer sold pharmacy subsidiaries PANTHERx and Magellan Rx last year. Centene is currently the fourth-largest insurer nationally, with 21,669,643 medical lives.

Source: AIS’s Directory of Health Plans

0 Comments
© 2024 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
May 23

Datapoint: Centene Pledges Nearly $1B for Affordable Housing

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
May 22

Datapoint: CMS Extends Medicaid Redetermination Deadline

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
May 21

Datapoint: Aetna Shut Out of Medicaid Contract Awards

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today